Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort

[1]  J. Habeshaw,et al.  The naive repertoire of human T helper cells specific for gp120, the envelope glycoprotein of HIV. , 1991, Journal of immunology.

[2]  A. Ades,et al.  Children born to women with HIV-1 infection: natural history and risk of transmission , 1991, The Lancet.

[3]  J. Weber,et al.  Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection. , 1991, BMJ.

[4]  P. Simmonds,et al.  Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users , 1990, The Lancet.

[5]  P. Simmonds,et al.  Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source , 2022 .

[6]  C. M. Steel,et al.  Five year prospective study of HIV infection in the Edinburgh haemophiliac cohort. , 1990, BMJ.

[7]  H. Watson,et al.  Confirmation of non-infection in persistently HIV-seronegative recipients of contaminated factor VIII , 1990, The Lancet.

[8]  S. Mallal,et al.  MHC genes and HIV infection , 1990, The Lancet.

[9]  J. Phair,et al.  A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection A report from the Multicenter AIDS Cohort Study , 1990, The Lancet.

[10]  M. Ascher,et al.  AIDS as immune system activation. II. The panergic imnesia hypothesis. , 1990, Journal of acquired immune deficiency syndromes.

[11]  J. Freedman,et al.  Two‐year evaluation of clinical and laboratory variables of immune function in 117 hemophiliacs seropositive or seronegative for HIV‐1 , 1989, American journal of hematology.

[12]  S. Zolla-Pazner,et al.  AIDS: a syndrome of immune dysregulation, dysfunction, and deficiency , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  F. de Wolf,et al.  Markers for progression in HIV infection , 1989, AIDS.

[14]  L. Lehr,et al.  Elevated serum levels of soluble interleukin 2 receptors in HIV infection: correlation studies with markers of cell activation. , 1988, Immunology letters.

[15]  P. Simmonds,et al.  HLA HAPLOTYPE A1 B8 DR3 AS A RISK FACTOR FOR HIV-RELATED DISEASE , 1988, The Lancet.

[16]  P. Simmonds,et al.  HIV antigen and antibody detection: variable responses to infection in the Edinburgh haemophiliac cohort , 1988, British medical journal.

[17]  J. Parry,et al.  PLACE OF IgM ANTIBODY TESTING IN HIV SEROLOGY , 1986, The Lancet.

[18]  J. Parry.  An immunoglobulin G capture assay (GACRIA) for anti‐HTLV III/LAV and its use as a confirmatory test , 1986, Journal of medical virology.

[19]  R. Prescott,et al.  HUMAN T-LYMPHOTROPIC VIRUS TYPE III (HTLV-III) INFECTION IN SERONEGATIVE HAEMOPHILIACS AFTER TRANSFUSION OF FACTOR VIII , 1985, The Lancet.

[20]  J. Sequí,et al.  Abnormal B cell function in haemophiliacs and their relationship with factor concentrates administration. , 1985, Clinical and experimental immunology.

[21]  R. Prescott,et al.  ABNORMALITIES OF CIRCULATING LYMPHOCYTE SUBSETS IN HAEMOPHILIACS IN AN AIDS-FREE POPULATION , 1984, The Lancet.

[22]  A. Dickinson,et al.  ALTERED IMMUNOLOGY IN HAEMOPHILIA , 1983, The Lancet.

[23]  R. Geha,et al.  Hyper immunoglobulin M immunodeficiency. (Dysgammaglobulinemia). Presence of immunoglobulin M-secreting plasmacytoid cells in peripheral blood and failure of immunoglobulin M-immunoglobulin G switch in B-cell differentiation. , 1979, The Journal of clinical investigation.